Gain Therapeutics (GANX) PT Lowered to $9 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts GANX Hot Sheet
Price: $2.12 -1.85%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Gain Therapeutics (NASDAQ: GANX) to $9.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Gain Therapeutics, Inc. (GANX) Tops Q2 EPS by 3c
- Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
